Association between serum cotinine levels and cognitive function in Americans aged 60 and older: A cross-sectional study
Open Access
- 22 May 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (21) , e48784
Abstract
Cognitive decline poses a major public health burden on the aging population, necessitating the identification of modifiable risk factors. Cotinine, a key nicotine metabolite and an established biomarker of tobacco exposure, has demonstrated biologically plausible associations with cognitive function. This study examined the association between serum cotinine levels and cognitive function in US adults aged ≥60 years. We conducted a cross-sectional study including 2781 participants aged ≥60 years, using data from the United States National Health and Nutrition Examination Survey from 2011 to 2014. Sampling weights were applied in all analyses to account for the complex survey design and ensure national representativeness. We used multivariable linear regression supplemented by stratified analyses, sensitivity analyses, and restricted cubic splines to model nonlinear associations. Multivariable-adjusted analyses showed a significant inverse association between serum cotinine levels and cognitive function (β = −0.85, 95% confidence interval: −1.62 to −0.08, P = .034). Subgroup analyses consistently demonstrated this inverse association across strata (all P for interaction > .05). Sensitivity analyses supported the robustness of these findings. Curve fitting revealed an L-shaped relationship (inflection point: log 2 cotinine = −0.16; 95% confidence interval: −0.30 to −0.03, P for nonlinearity = .022), with a significant inverse association observed below this threshold ( P = .017), whereas the association plateaued above the threshold ( P = .063), suggesting a potential threshold-dependent association between serum cotinine and cognitive function. This cross-sectional study found a significant inverse association between serum cotinine levels and cognitive function in older adults in the United States, which was observed as an L-shaped relationship with a threshold of log 2 cotinine = −0.16. These findings contribute to evidence on tobacco exposure and cognitive outcomes in aging populations.Keywords
This publication has 63 references indexed in Scilit:
- Estimating regression models with unknown break‐pointsStatistics in Medicine, 2003
- Nicotinic acetylcholine receptors: from structure to brain function2003
- Dementia diagnosis in developing countries: a cross-cultural validation studyThe Lancet, 2003
- Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometryClinical Chemistry, 1997
- Safety of Cotinine in Humans: Physiologic, Subjective, and Cognitive EffectsPharmacology Biochemistry and Behavior, 1997
- Presynaptic nicotinic ACh receptorsTrends in Neurosciences, 1997
- Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysisJournal of Clinical Epidemiology, 1996
- Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991.1996
- Cotinine as a Biomarker of Environmental Tobacco Smoke ExposureEpidemiologic Reviews, 1996
- Simulation Study of Confounder-Selection StrategiesAmerican Journal of Epidemiology, 1993